AYTU — Aytu Biopharma Cashflow Statement
0.000.00%
Last trade - 00:00- $6.85m
- $2.30m
- $81.00m
- 62
- 77
- 54
- 71
Annual cashflow statement for Aytu Biopharma, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -13.6 | -58.3 | -110 | -17.1 | -15.8 |
| Depreciation | |||||
| Non-Cash Items | -8.39 | 21.4 | 82 | 8.91 | 10.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -12.6 | 1.68 | -10.9 | -5.8 | -4.66 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -28.4 | -26 | -28.8 | -5.13 | -1.39 |
| Capital Expenditures | 0 | -2.34 | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -5.66 | -0.441 | -3.25 | -0.117 | -0.329 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -5.66 | -2.78 | -3.25 | -0.117 | -0.329 |
| Financing Cash Flow Items | -5.4 | -11 | -4.94 | -4.36 | -2.84 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 71.1 | 30.3 | 1.53 | 8.87 | -1.26 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 37 | 1.57 | -30.5 | 3.63 | -2.98 |